 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-6-2022
Insider Buy |
Sujal Shah
Chief Executive Officer |
$1.95
CAGR »
|
$100,036.95
51,301 shares |
1-19-2022
Insider Buy |
Dennis D. Kim
Chief Medical Officer |
$3.04
CAGR »
|
$60,800.00
20,000 shares |
10-10-2019
Insider Buy |
Sujal Shah
Chief Executive Officer |
$4.30
CAGR »
|
$21,500.00
5,000 shares |
9-23-2019
Insider Buy |
Sujal Shah
Chief Executive Officer |
$5.53
CAGR »
|
$27,655.00
5,000 shares |
12-21-2018
Insider Buy |
Sujal Shah
Chief Executive Officer |
$6.54
CAGR »
|
$65,399.00
10,000 shares |
10-15-2018
Insider Buy |
Sujal Shah
Chief Executive Officer |
$9.90
CAGR »
|
$49,500.00
5,000 shares |
7-27-2018
Insider Buy |
Sujal Shah
Chief Executive Officer |
$10.90
CAGR »
|
$54,500.00
5,000 shares |
5-11-2018
Insider Buy |
Sujal Shah
Chief Executive Officer |
$10.65
CAGR »
|
$53,250.00
5,000 shares |
11-2-2017
Insider Buy |
Charles McWherter
SVP & Chief Scientific Officer |
$8.67
CAGR »
|
$43,340.60
5,000 shares |
8-1-2017
Insider Buy |
Robert James Wills
Director |
$6.84
CAGR »
|
$34,220.70
5,000 shares |
7-20-2017
Insider Buy |
Sujal Shah
Interim President & CEO |
$7.34
CAGR »
|
$73,400.50
10,000 shares |
7-20-2017
Insider Buy |
Charles McWherter
SVP & Chief Scientific Officer |
$7.43
CAGR »
|
$37,137.30
5,000 shares |
9-6-2016
Insider Buy |
Robert James Wills
Director |
$2.43
CAGR »
|
$60,857.50
25,000 shares |
4-15-2016
Insider Buy |
Charles McWherter
Sr. Vice President |
$1.68
CAGR »
|
$5,040.00
3,000 shares |
4-15-2016
Insider Buy |
Patrick J. Omara
VP, Business Development |
$1.64
CAGR »
|
$8,200.00
5,000 shares |
4-5-2016
Insider Buy |
Sujal Shah
Chief Financial Officer |
$1.39
CAGR »
|
$76,450.00
55,000 shares |
8-14-2015
Insider Buy |
Kurt Von Emster
Director |
$2.69
CAGR »
|
$242,474.39
90,000 shares |
7-20-2015
Insider Buy |
Kurt Von Emster
Director |
$2.81
CAGR »
|
$4,496,000.00
1,600,000 shares |
5-18-2015
Insider Buy |
Sujal Shah
Chief Financial Officer |
$3.40
CAGR »
|
$34,000.00
10,000 shares |
5-18-2015
Insider Buy |
Harold Van Wart
President and CEO |
$3.34
CAGR »
|
$25,039.00
7,500 shares |
5-15-2015
Insider Buy |
Charles McWherter
Sr. Vice President |
$3.16
CAGR »
|
$6,318.40
2,000 shares |
Also See: Institutional Holders of CBAY
Also See: SEC filings
Below we present the annualized performance delivered by CBAY stock since 6-6-2022 (the date of the most recent
insider purchase). The performance of the investment from the time CBAY insider buying occurred is the ultimate
test of whether insiders were right about CBAY being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/07/2022 |
|
| End date: |
03/22/2024 |
|
| Start price/share: |
$2.32 |
|
| End price/share: |
$32.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,300.00% |
|
| Average Annual Total Return: |
336.17% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$139,998.37 |
|
| Years: |
1.79 |
|
CBAY Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CBAY insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CBAY
|
|
Free CBAY Email Alerts:
